Craig Gracey Sells 637 Shares of Omada Health (NASDAQ:OMDA) Stock

by · The Markets Daily

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CAO Craig Gracey sold 637 shares of Omada Health stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $23.00, for a total transaction of $14,651.00. Following the sale, the chief accounting officer directly owned 15,441 shares of the company’s stock, valued at $355,143. This represents a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Craig Gracey also recently made the following trade(s):

  • On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The shares were sold at an average price of $22.00, for a total value of $8,910.00.
  • On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $21.00, for a total value of $43,743.00.
  • On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The stock was sold at an average price of $20.00, for a total value of $41,680.00.
  • On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
  • On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total transaction of $37,494.00.
  • On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Stock Performance

Shares of Omada Health stock opened at $22.39 on Friday. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The company has a fifty day moving average of $17.32 and a 200-day moving average of $15.08. The stock has a market capitalization of $1.33 billion and a price-to-earnings ratio of -82.93.

Omada Health (NASDAQ:OMDA – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The company had revenue of $78.05 million for the quarter. On average, equities research analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on OMDA shares. Wells Fargo & Company raised their price target on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Citigroup reiterated an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. Evercore reissued an “outperform” rating and set a $20.00 price target on shares of Omada Health in a research report on Friday, May 8th. Finally, Citizens Jmp raised their price target on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a report on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Get Our Latest Research Report on OMDA

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Geode Capital Management LLC bought a new stake in shares of Omada Health during the second quarter valued at approximately $637,000. Walleye Capital LLC bought a new position in Omada Health in the second quarter worth $458,000. Ilex Capital Partners UK LLP purchased a new position in Omada Health during the second quarter valued at $201,000. Soros Fund Management LLC purchased a new position in Omada Health during the second quarter valued at $640,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Omada Health during the 2nd quarter valued at $32,000.

Omada Health Company Profile

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Featured Stories